Additionally, in MS4A, SPI1, TP53INP1 and ZYX loci both computational approaches pointed to the same candidate causal genes (albeit nominating different enhancers), while in BIN1 and RABEP1 loci both approaches pointed to the same AD risk enhancers and target gene (Fig. 2a). This evidence concerns the gene RABEP1 and Alzheimer disease.